| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_34d84d92eec9f232ace0dcb0df59c22c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_faf522b8b83eded745c73018576219ba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fcc0b66123940d1b32783569ebfa2d45
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf6edae5250129896be5ca2e33a61ed3 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6875 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| filingDate |
2013-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a33b94ed47152569415e9a58b627d35a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d3585b6f10a8684b7851d09073a81ca8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e64dd8a4a3e260f1f6afd896fecd49f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b292bf5e6c6246e27ce01133d37c9808
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c51ea4fb2824a0ac4ccf89dab5acfbfc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d62ca862e1645db3cd74580061583462
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c988dfeed994898d0c84b49e9a134536 |
| publicationDate |
2013-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2013191280-A1 |
| titleOfInvention |
Agent for treating or preventing systemic inflammatory response syndrome |
| abstract |
The present invention provides an agent for treating or preventing systemic inflammatory response syndrome (SIRS) containing: a polypeptide comprising the same or substantially the same amino acid sequence as the N-terminus domain of pentraxin 3, able to bind to histones to form a polypeptide aggregate; or a pharmacologically acceptable salt thereof. The present invention also provides a quantifying method and reagent for quantifying histones using said polypeptide or pharmacologically acceptable salt thereof. The present invention furthermore provides a polypeptide aggregate comprising said polypeptide or pharmacologically acceptable salt thereof and histones, and a method for producing the same. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019536062-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10639405-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7173495-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2016013540-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11391742-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021230233-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016013540-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018510358-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11740245-B2 |
| priorityDate |
2012-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |